Drugs / FMX103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02601963 | Sep 2015 → Aug 2016 | rosacea | Vyne Therapeutics Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMX103 | “A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial...” PMID 29396702 ↗ Jun 2018 |
| Route | Topical | “Topical Minocycline Foam, FMX103” PMID 29396702 ↗ Jun 2018 |